Jarvis J N, Diebold M M, Chadwell M K, Iobidze M, Moore H T
Department of Paediatrics, Wayne State University School of Medicine, Detroit, MI, USA.
Clin Exp Immunol. 1995 Jun;100(3):514-8. doi: 10.1111/j.1365-2249.1995.tb03731.x.
Data published from in vitro studies have shown that IgM-rheumatoid factor (RF)-bearing immune complexes possess several biological features that may contribute to their pathogenicity. However, no studies have demonstrated that such complexes exist at sites of inflammation in children with rheumatoid disease. We used two methods of sequential column chromatography to purify immune complexes from synovial fluids of children with JRA. We demonstrate that high molecular weight complexes contain IgM-RF, have not bound C4 in vivo, but activate the classical pathway in vitro. In contrast, complexes which have bound C3 in vivo do not contain IgM-RF and are weak complement activators in vitro.
体外研究发表的数据表明,携带IgM类风湿因子(RF)的免疫复合物具有多种生物学特性,这些特性可能导致其致病性。然而,尚无研究表明此类复合物存在于类风湿病患儿的炎症部位。我们使用两种连续柱色谱法从幼年特发性关节炎(JRA)患儿的滑液中纯化免疫复合物。我们证明,高分子量复合物含有IgM-RF,在体内未结合C4,但在体外可激活经典途径。相比之下,在体内已结合C3的复合物不含IgM-RF,且在体外是弱补体激活剂。